Page last updated: 2024-08-23

paroxetine and Basal Ganglia Diseases

paroxetine has been researched along with Basal Ganglia Diseases in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (42.86)	18.2507
2000's	1 (14.29)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Konstantinou, G; Mylona, S; Paschalakis, G; Stavrinou, A; Vasilopoulou, P	1
Carleton, BC; Etminan, M; Guo, MY; Kezouh, A; Kim, DD; Procyshyn, RM; Samii, A	1
Kagawa, S; Kondo, T; Mihara, K; Nagai, G; Nakamura, A; Nemoto, K; Suzuki, T	1
Bhanji, NH; Margolese, HC	1
Allen, SA; Malek-Ahmadi, P	1
Arya, DK; McKenzie, J; Worrall, N	1
Nicholson, SD	1

Trials

1 trial(s) available for paroxetine and Basal Ganglia Diseases

Article	Year
Effects of paroxetine on plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia. Therapeutic drug monitoring, 2012, Volume: 34, Issue:2 Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Asian People; Basal Ganglia Diseases; Chromatography, Liquid; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Japan; Male; Mass Spectrometry; Middle Aged; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Young Adult	2012

Article

Year

Effects of paroxetine on plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia.

Therapeutic drug monitoring, 2012, Volume: 34, Issue:2

Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Asian People; Basal Ganglia Diseases; Chromatography, Liquid; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Japan; Male; Mass Spectrometry; Middle Aged; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Young Adult

2012

Other Studies

6 other study(ies) available for paroxetine and Basal Ganglia Diseases

Article	Year
Basal Ganglia Calcification: A Case Report of Fahr Disease With Pure Psychiatric Symptoms. Journal of psychiatric practice, 2019, Volume: 25, Issue:5 Topics: Basal Ganglia; Basal Ganglia Diseases; Calcinosis; Depression; Diagnosis, Differential; Female; Humans; Mental Disorders; Middle Aged; Neurodegenerative Diseases; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Psychotropic Drugs; Tomography, X-Ray Computed; Treatment Outcome	2019
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study. Journal of clinical psychopharmacology, 2018, Volume: 38, Issue:4 Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pharmacoepidemiology; Sertraline; United States; Venlafaxine Hydrochloride	2018
Extrapyramidal symptoms related to adjunctive nizatidine therapy in an adolescent receiving quetiapine and paroxetine. Pharmacotherapy, 2004, Volume: 24, Issue:7 Topics: Adolescent; Basal Ganglia Diseases; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Nizatidine; Paroxetine; Quetiapine Fumarate	2004
Paroxetine-molindone interaction. The Journal of clinical psychiatry, 1995, Volume: 56, Issue:2 Topics: Aged; Basal Ganglia Diseases; Delusions; Depressive Disorder; Drug Interactions; Female; Humans; Molindone; Parkinson Disease, Secondary; Paroxetine	1995
Exacerbation of extrapyramidal symptoms with paroxetine. The Australian and New Zealand journal of psychiatry, 1995, Volume: 29, Issue:3 Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Basal Ganglia Diseases; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Paroxetine	1995
Extra pyramidal side effects associated with paroxetine. West of England medical journal, 1992, Volume: 107, Issue:3 Topics: Adult; Basal Ganglia Diseases; Drug Therapy, Combination; Humans; Male; Paranoid Disorders; Paroxetine; Trifluoperazine	1992